If you continue to have this issue please contact [email protected]. More than 80% of Omvoh responders from the VIVID-1 study maintained endoscopic response at week 104 in VIVID-2.

The approval is for both a 3 mL single-patient-use prefilled pen and a 10 mL multiple-dose vial. "For the millions of people who rely on daily injections of insulin for treatment of diabetes ...

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

Blanco gave his fiancée a rather unique gift for Valentine's Day, laying tortilla chips around her house and filling her bathtub with cheese Charlotte Phillipp is a Weekend Writer-Reporter at ...

The green light for the pre-filled, single-use pen version of Tezspire (tezepelumab) comes just four months after the TSLP inhibitor became the first biologic therapy for severe asthma to be ...

In the past two years, Lilly has received approvals for several new drugs like Kisunla, Omvoh and Jaypirca. Its new drugs contributed significantly to its top-line growth in 2024. Lilly is also making ...

SAE Media Group's 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference 2023 will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for ...

Canada and the United States have played some heated games on hockey's international stage. The rivalry reached a new — and nasty — level Saturday. Dylan Larkin scored the go-ahead goal in the second ...

The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh® (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn ...

Jena-based German biotech InflaRx (Nasdaq: IFRX) has announced the pricing of an underwritten public offering, raising approximately $30 million. Guggenheim Securities is acting as the book-running ...